In vitro studies on the mechanism of action of VEGF and its inhibitors on blood-retina barrier
Acta Ophthalmologica, 08/09/2012
Deissler H et al. – VEGF is mainly responsible for disrupting the barrier function of REC. This supports VEGF targeting as a therapeutic concept. Independent research grant by Novartis Pharma, Germany.